MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,263,004 | -53.1% | 258,563 | -59.9% | 0.03% | -55.4% |
| Q1 2023 | $23,999,690 | -29.7% | 645,500 | -14.3% | 0.07% | -36.2% |
| Q4 2022 | $34,145,616 | +380.0% | 753,600 | +639.9% | 0.12% | +314.3% |
| Q3 2022 | $7,113,000 | -65.9% | 101,847 | -67.2% | 0.03% | -68.2% |
| Q2 2022 | $20,851,000 | -70.4% | 310,600 | -35.3% | 0.09% | -68.7% |
| Q4 2021 | $70,388,000 | +989.4% | 479,845 | +1099.6% | 0.28% | +869.0% |
| Q2 2021 | $6,461,000 | -85.9% | 40,000 | -85.0% | 0.03% | -86.4% |
| Q1 2021 | $45,806,000 | -3.2% | 267,400 | +24.1% | 0.21% | -7.4% |
| Q4 2020 | $47,324,000 | +122.0% | 215,463 | +15.4% | 0.23% | +66.2% |
| Q2 2020 | $21,318,000 | -73.1% | 186,721 | -81.6% | 0.14% | -71.4% |
| Q3 2019 | $79,162,000 | +87.9% | 1,016,069 | +148.5% | 0.49% | +120.9% |
| Q2 2019 | $42,120,000 | +3240.2% | 408,935 | +2277.5% | 0.22% | +3566.7% |
| Q1 2019 | $1,261,000 | +72.7% | 17,200 | +11.0% | 0.01% | +100.0% |
| Q3 2018 | $730,000 | -94.2% | 15,500 | -96.2% | 0.00% | -94.2% |
| Q1 2018 | $12,523,000 | +748.4% | 407,929 | +404.2% | 0.05% | +766.7% |
| Q4 2017 | $1,476,000 | – | 80,899 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
| ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
| Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
| Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
| Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
| Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
| Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
| RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
| Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |